Replimune REPL
NASDAQ REPL
$15.02 -0.27 (-1.77%)
As of: Sep 4, 2026 · 2:19 PM EDT

Replimune (REPL) Debt Ratio (2019 - 2026)

Replimune (REPL) posted Debt Ratio of 0.25 for Q1 2026, up 75.55% sequentially from 0.14 in Q4 2025, and up 197.95% YoY from 0.08 in Q1 2025.

Analysis

Replimune (REPL) Debt Ratio (2019 - 2026) Analysis & Trends

Replimune has reported Debt Ratio for 7 years, with the latest figure at 0.25 in Q1 2026.

  • Quarterly Debt Ratio rose 197.95% year-over-year to 0.25 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.25 (up 197.95% YoY) and the FY2026 annual result came in at 0.25, up 197.95% from the prior year.
  • Debt Ratio grew to 0.25 in Q1 2026 per REPL's latest filing, from 0.14 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.25 in Q1 2026 and troughed at 0.04 in Q4 2022.
  • A 5-year average of 0.09 and a median of 0.08 in 2024 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2024 and 2026: Debt Ratio slipped 8.68% in 2024, then soared 197.95% in 2026.
  • Over 5 years, Debt Ratio stood at 0.04 in 2022, then jumped by 99.28% to 0.08 in 2023, then dropped by 8.68% to 0.08 in 2024, then surged by 87.52% to 0.14 in 2025, then soared by 75.55% to 0.25 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods registered 0.25, 0.14, and 0.12 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 0.05
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn -
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn 0.05
5 Revolution Medicines 44.08 Bn 44.08 Bn - -
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 0.12
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.59 Bn - 0.47
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 0.26
10 Replimune 1.45 Bn 1.45 Bn - 0.33
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.33
Mar 31, 2026 0.25
Dec 31, 2025 0.14
Sep 30, 2025 0.12
Jun 30, 2025 0.10
Mar 31, 2025 0.08
Dec 31, 2024 0.08
Sep 30, 2024 0.09
Jun 30, 2024 0.08
Mar 31, 2024 0.09
Dec 31, 2023 0.08
Sep 30, 2023 0.05
Jun 30, 2023 0.05
Mar 31, 2023 0.04
Dec 31, 2022 0.04
Sep 30, 2020 0.03
Jun 30, 2020 0.03
Mar 31, 2020 0.04
Dec 31, 2019 0.04
Sep 30, 2019 0.06